In all, our results demonstrated that NCL overexpression enhances NFκB activity and subsequently promotes DNMT1 expression, which is followed by global DNA hypermethylation and epigenetic silencing of TSG transcription, thus, conferring a survival advantage to leukemia cells (Fig. 7H). The gene discussed is NUCLEOLIN; the disease is leukemia.